Biopharma Competition Patients Relationship management 
pharmaphorum
AUGUST 5, 2022
Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace.
PM360
NOVEMBER 27, 2023
I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. Now, due to the highly competitive environment, the process is truncated to 12-18 months. Marketing is key to adding that layer of storytelling.
Expert insights. Personalized for you.
52 
Let's personalize your content